Recalls / Class II
Class IID-0910-2023
Product
allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.
- Affected lot / code info
- Lot #: a) 2HE2032, 2JE1882, 2JE2185 Exp. Date 01/24; b) 2DR0464, 2ER0410, Exp. Date 12/23; 2ER0286, 2ER0411, Exp. Date 01/24 c) 2DR0467, 2DR0468, 2DR0469, 2ER0288, Exp. Date 12/23 d) 2ER0414, Exp. Date 01/24, 2GR0333, Exp. Date 02/24
Why it was recalled
Failed Impurities/Degradation Specifications
Recalling firm
- Firm
- L. Perrigo Company
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 515 Eastern Ave, N/A, Allegan, Michigan 49010-9070
Distribution
- Quantity
- 208,416 cartons
- Distribution pattern
- Nationwide within the USA
Timeline
- Recall initiated
- 2023-02-09
- FDA classified
- 2023-07-11
- Posted by FDA
- 2023-07-19
- Terminated
- 2023-09-11
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0910-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.